183 related articles for article (PubMed ID: 25411947)
1. Analysis of the d3-growth hormone receptor polymorphism in large cohorts of small, appropriate and large for gestational age newborns.
Vincenzi M; Ion Popa F; Corradi M; Gandini A; Teofoli F; Camilot M; Boner A; Cavarzere P; Gaudino R; Antoniazzi F
Minerva Pediatr; 2016 Jun; 68(3):157-61. PubMed ID: 25411947
[TBL] [Abstract][Full Text] [Related]
2. Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA.
Audí L; Esteban C; Carrascosa A; Espadero R; Pérez-Arroyo A; Arjona R; Clemente M; Wollmann H; Fryklund L; Parodi LA;
J Clin Endocrinol Metab; 2006 Dec; 91(12):5038-43. PubMed ID: 17003087
[TBL] [Abstract][Full Text] [Related]
3. The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects.
Jensen RB; Vielwerth S; Larsen T; Greisen G; Leffers H; Juul A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2758-63. PubMed ID: 17426087
[TBL] [Abstract][Full Text] [Related]
4. The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adults.
Martins CS; Fernandes-Rosa FL; Espineira AR; de Souza RM; de Castro M; Barbieri MA; Bettiol H; Jorge AL; Antonini SR
Growth Horm IGF Res; 2014 Aug; 24(4):123-9. PubMed ID: 24893921
[TBL] [Abstract][Full Text] [Related]
5. The growth hormone receptor gene deleted for exon three (GHRd3) polymorphism is associated with birth and placental weight.
Padidela R; Bryan SM; Abu-Amero S; Hudson-Davies RE; Achermann JC; Moore GE; Hindmarsh PC
Clin Endocrinol (Oxf); 2012 Feb; 76(2):236-40. PubMed ID: 21913951
[TBL] [Abstract][Full Text] [Related]
6. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.
Carrascosa A; Audí L; Fernández-Cancio M; Esteban C; Andaluz P; Vilaró E; Clemente M; Yeste D; Albisu MA; Gussinyé M
J Clin Endocrinol Metab; 2008 Mar; 93(3):764-70. PubMed ID: 18160465
[TBL] [Abstract][Full Text] [Related]
7. Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children.
Dörr HG; Bettendorf M; Hauffa BP; Mehls O; Rohrer T; Stahnke N; Pfäffle R; Ranke MB;
Clin Endocrinol (Oxf); 2011 Nov; 75(5):656-60. PubMed ID: 21623854
[TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin levels and adiponectin +276 G/T gene polymorphism in newborns with large and small birth weights.
Yalinbas EE; Akcilar R
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10638-10646. PubMed ID: 36415042
[TBL] [Abstract][Full Text] [Related]
9. The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.
Audí L; Carrascosa A; Esteban C; Fernández-Cancio M; Andaluz P; Yeste D; Espadero R; Granada ML; Wollmann H; Fryklund L;
J Clin Endocrinol Metab; 2008 Jul; 93(7):2709-15. PubMed ID: 18445665
[TBL] [Abstract][Full Text] [Related]
10. GH receptor d3 polymorphism in Dutch patients with MPHD and IGHD born small or appropriate for gestational age.
de Graaff LC; Meyer S; Els C; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Jun; 68(6):930-4. PubMed ID: 18031312
[TBL] [Abstract][Full Text] [Related]
11. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
Szmit-Domagalska J; Petriczko E; Drozdzynska M; Adler G; Horodnicka-Jozwa A; Ciechanowicz A; Walczak M
Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for-Gestational-Age Children.
Carrascosa A; Audí L; Esteban C; Fernández-Cancio M; Andaluz P; Gussinyé M; Clemente M; Yeste D; Albisu MA
J Clin Endocrinol Metab; 2008 Jan; 93(1):147-53. PubMed ID: 17925340
[TBL] [Abstract][Full Text] [Related]
13. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
[TBL] [Abstract][Full Text] [Related]
14. The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS).
Wegmann MG; Thankamony A; Roche E; Hoey H; Kirk J; Shaikh G; Ivarsson SA; Söder O; Dunger DB; Juul A; Jensen RB
Growth Horm IGF Res; 2017 Aug; 35():45-51. PubMed ID: 28719834
[TBL] [Abstract][Full Text] [Related]
15. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
16. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.
Carrascosa A; Esteban C; Espadero R; Fernández-Cancio M; Andaluz P; Clemente M; Audí L; Wollmann H; Fryklund L; Parodi L;
J Clin Endocrinol Metab; 2006 Sep; 91(9):3281-6. PubMed ID: 16804042
[TBL] [Abstract][Full Text] [Related]
17. Derivation and assessment of a sex-specific fetal growth standard.
Blue NR; Allshouse AA; Heerboth S; Grobman W; Mercer B; Shanks A; Bregand-White JM; Simhan H; Reddy UM; Saade G; Parry S; Silver RM
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9913-9921. PubMed ID: 35603475
[TBL] [Abstract][Full Text] [Related]
18. MTHFR 677 C > T Gene Polymorphism is Associated with Large for Gestational Age Infants.
Akcılar R; Yalınbaş EE; Mutlu F
Fetal Pediatr Pathol; 2024; 43(3):234-245. PubMed ID: 38743580
[TBL] [Abstract][Full Text] [Related]
19. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
[TBL] [Abstract][Full Text] [Related]
20. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population.
Baş F; Keleşoğlu F; Timirci Ö; Kabataş Eryılmaz S; Bozkurt N; Küçükemre Aydın B; Bundak R; Isbir T; Darendeliler F
J Clin Res Pediatr Endocrinol; 2011; 3(3):126-31. PubMed ID: 21911325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
